雅虎香港 搜尋

搜尋結果

  1. special reports. In an interview with MIMS Doctor, Dr Ka-Yuen Lock, Specialist in Endocrinology, Diabetes and Metabolism in Hong Kong, discussed management of diabetes mellitus (DM), including use of ultra-long-acting insulin, in optimizing glycaemic control. She also shared a case study illustrating improvements in glucose variability and ...

  2. Search drug information, interaction, images & medical diagnosis. The most comprehensive database of medicines available in China, Hong Kong, Taiwan, Malaysia, Singapore, Philippines, Vietnam, Thailand, Indonesia and India Register for a MIMS account and ...

  3. DME Administer 6 mg (0.05 mL soln) every 6 wk for the 1st 5 doses, may be individualised thereafter based on disease activity. Patient w/o disease activity Consider treatment every 12 wk (3 mth). Patient w/ disease activity Consider treatment every 8 wk (2 mth). Click to view Beovu detailed prescribing information.

  4. Dosage/Direction for Use. Cream Apply to affected skin areas once daily (evening). Duration of treatment: Generally, 2-3 wk, 6 wk in foot mycoses. Continue treatment for several days after clinical use. Nail lacquer Apply to affected finger or toe nails once wkly after filing & cleansing. Treat finger nail for 6 mth, toe nail for 9-12 mth.

  5. Dosage/Direction for Use. IM Primary vaccination schedule of 2 doses (0.5 mL each): Initial dose followed by 2nd dose 2 mth later. If flexibility in the vaccination schedule is necessary, 2nd dose can be administered between 2 & 6 mth after the 1st dose. Immunodeficient or immunosuppressed individual 2nd dose can be given 1-2 mth after the ...

  6. Dosage/Direction for Use. Adult Initially 0.5 mg qds or 1 mg bd. Ped patient Initially 0.5 mg daily. Dose may be titrated after 1 wk. Max dose increment: 0.5 mg daily in any 1 wk. Max dose: 10 mg daily or 2.5 mg as single dose. Patient w/ moderate hepatic impairment (Child Pugh score 7-9) Initially 0.5 mg daily, may be increased if therapy has ...

  7. Dexaltin Oral Paste is thus effective against inflammatory diseases of the oral cavity. Chemical name: 9-Fluoro-11β,17,21-trihydroxy-16α-methylpregna-l,4-diene-3,20-dione. Molecular formula: C 22 H 29 FO 5. Molecular weight: 392.47. Dexamethasone occurs as white to light yellow crystals or a crystalline powder.